Product image
InVivoMAb anti-mouse CXCL9 (MIG)
BE0309
ApplicationsImmunoFluorescence, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CXCL9 (MIG)
- Delivery Days Customer7
- ApplicationsImmunoFluorescence, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMIG-2F5.5
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHamster
- IsotypeIgG
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade. Wang C et al., 2021 Nov 23, Cell RepRead more
- PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. Moreno-Fernandez ME et al., 2021 Jun 1, Cell MetabRead more
- Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment. Qu Y et al., 2020 Sep 1, Cell RepRead more
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Dangaj D et al., 2019 Jun 10, Cancer CellRead more
- T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. Xiong Y et al., 2016 Mar 15, J ImmunolRead more
- Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjoegrens syndrome in a mouse model. Jin JO et al., 2013, PLoS OneRead more
- Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Sung JH et al., 2012 Sep 14, CellRead more